Table 4 Comparison of the drug resistance of major gram-positive bacteria to commonly used antibacterial agents between nosocomial and community-acquired SBP
Antibiotics | Staphylococcus aureus (n = 16) | Enterococcus (n = 54) | ||||
|---|---|---|---|---|---|---|
Nosocomial (n = 9) | Community-acquired (n = 7) | p value | Nosocomial (n = 43) | Community-acquired (n = 11) | p value | |
Penicillin | 8 (88.9) | 5 (71.4) | 0.550 | 37 (86.0) | 8 (72.7) | 0.546 |
Oxacillin | 6 (66.7) | 3 (42.9) | 0.615 | – | – | – |
Erythromycin | 8 (88.9) | 4 (57.1) | 0.262 | 36 (83.7) | 6 (54.5) | 0.038 |
Clindamycin | 7 (77.8) | 1 (14.3) | 0.041 | – | – | – |
Nitrofurantoin | 0 | 0 | NS | 25 (58.1) | 2 (18.2) | 0.043 |
Rifampicin | 0 | 0 | NS | 37 (86.0) | 8 (72.7) | 0.546 |
Tetracycline | 4 (44.4) | 2 (28.6) | 0.633 | 24 (55.8) | 6 (54.5) | 0.940 |
Ciprofloxacin | 5 (55.6) | 2 (28.6) | 0.358 | 32 (74.4) | 8 (72.7) | 0.909 |
SMZ | 1 (11.1) | 1 (14.3) | NS | – | – | – |
Linezolid | 0 | 0 | NS | 0 | 0 | NS |
Vancomycin | 0 | 0 | NS | 8 (18.6) | 1 (9.1) | 0.762 |
Teicoplanin | 0 | 0 | NS | 4 (9.3) | 0 | 0.571 |